Literature DB >> 33204373

Correlation of texture feature analysis with bone marrow infiltration in initial staging of patients with lymphoma using 18F-fluorodeoxyglucose positron emission tomography combined with computed tomography.

Mahmoud A Kenawy1, Magdy M Khalil2, Mahmoud H Abdelgawad1, H H El-Bahnasawy1.   

Abstract

PURPOSE: To explore whether radiomic features of fluorine-18-fluorodeoxyglucose (18F-FDG) positron emission tomo-graphy-computed tomography (PET/CT) has association with bone marrow infiltration (BMI) in comparison to other conventional PET metrics.
MATERIAL AND METHODS: Forty-four patients (with pathologically proven lymphoma disease) underwent staging 18F-FDG PET/CT scan. Primary tumour was semi-automatically or manually segmented with a threshold standardised uptake value (SUV) of 3. A total of 73 features were extracted from eight different textures. Spearman correlation was used to test the correlation of features with conventional quantitative metrics such as SUV, metabolic tumour volume, and total lesion glycolysis. Specificity and sensitivity (including 95% confidence intervals [CI]) for each of the studied parameters were derived using receiver operative characteristic (ROC) curves. Univariate and multivariate analyses were used to identify independent predictors associated with BMI.
RESULTS: Correlation between conventional PET metrics and features ranged between 0.50 and 0.97 for positive correlation (33 significant association features) and ranged from -0.52 to -0.97 for inverse correlation (three significant association features) for both strong and moderate correlations. Analysis of ROC curves showed that high-intensity long-run emphasis 4 bin, high-intensity large zone emphasis 64 bin, long-run emphasis (LRE) 64 bin, large-zone emphasis 64 bin, max spectrum 8 bin, busyness 64 bin, and code similarity 32 and 64 bin were significant discriminators of BMI among other features (area under curve > 0.682, p < 0.05). Univariate analyses of texture features showed that code similarity and long-run emphasis (both 64 bin) were significant predictors of bone marrow involvement. Multivariate analyses revealed that LRE (64 bin, p = 0.031) with an odds ratio of 1.022 and 95% CI of (1.002-1.043) were independent variables for bone marrow involvement.
CONCLUSIONS: 18F-FDG PET/CT radiomic features are synergistic to visual assessment of BMI in patients diagnosed with lymphoma using 18F-FDG PET/CT. Further assessment of long-run emphasis is highly warranted. © Pol J Radiol 2020.

Entities:  

Keywords:  18F-FDG PET/CT; bone marrow; radiomics; texture analysis

Year:  2020        PMID: 33204373      PMCID: PMC7654316          DOI: 10.5114/pjr.2020.99833

Source DB:  PubMed          Journal:  Pol J Radiol        ISSN: 1733-134X


  37 in total

Review 1.  The use of standardized uptake values for assessing FDG uptake with PET in oncology: a clinical perspective.

Authors:  G Lucignani; G Paganelli; E Bombardieri
Journal:  Nucl Med Commun       Date:  2004-07       Impact factor: 1.690

Review 2.  Texture analysis of medical images.

Authors:  G Castellano; L Bonilha; L M Li; F Cendes
Journal:  Clin Radiol       Date:  2004-12       Impact factor: 2.350

Review 3.  Imaging in staging of malignant lymphoma: a systematic review.

Authors:  Thomas C Kwee; Robert M Kwee; Rutger A J Nievelstein
Journal:  Blood       Date:  2007-10-04       Impact factor: 22.113

4.  Risk-adapted dose-dense immunochemotherapy determined by interim FDG-PET in Advanced-stage diffuse large B-Cell lymphoma.

Authors:  Craig H Moskowitz; Heiko Schöder; Julie Teruya-Feldstein; Camelia Sima; Alexia Iasonos; Carol S Portlock; David Straus; Ariela Noy; Maria L Palomba; Owen A O'Connor; Steven Horwitz; Sarah A Weaver; Jessica L Meikle; Daniel A Filippa; James F Caravelli; Paul A Hamlin; Andrew D Zelenetz
Journal:  J Clin Oncol       Date:  2010-03-08       Impact factor: 44.544

5.  Intensity of 18fluorodeoxyglucose uptake in positron emission tomography distinguishes between indolent and aggressive non-Hodgkin's lymphoma.

Authors:  Heiko Schöder; Ariela Noy; Mithat Gönen; Lijun Weng; David Green; Yusuf E Erdi; Steven M Larson; Henry W D Yeung
Journal:  J Clin Oncol       Date:  2005-04-18       Impact factor: 44.544

6.  FDG PET/CT versus CT, MR imaging, and 67Ga scintigraphy in the posttherapy evaluation of malignant lymphoma.

Authors:  Masahiro Okada; Norihide Sato; Kazunari Ishii; Kaname Matsumura; Makoto Hosono; Takamichi Murakami
Journal:  Radiographics       Date:  2010 Jul-Aug       Impact factor: 5.333

7.  Correlations between metabolic texture features, genetic heterogeneity, and mutation burden in patients with lung cancer.

Authors:  Seung Hwan Moon; Jinho Kim; Je-Gun Joung; Hongui Cha; Woong-Yang Park; Jin Seok Ahn; Myung-Ju Ahn; Keunchil Park; Joon Young Choi; Kyung-Han Lee; Byung-Tae Kim; Se-Hoon Lee
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-08-25       Impact factor: 9.236

8.  Current status of PET/CT in the diagnosis and follow up of lymphomas.

Authors:  Carlos Alberto Buchpiguel
Journal:  Rev Bras Hematol Hemoter       Date:  2011

9.  FDG-PET/CT in lymphoma.

Authors:  Maria M D'souza; Abhinav Jaimini; Abhishek Bansal; Madhavi Tripathi; Rajnish Sharma; Anupam Mondal; Rajendra Prashad Tripathi
Journal:  Indian J Radiol Imaging       Date:  2013-10

10.  Pattern of bone marrow involvement in non Hodgkin's lymphoma classified according to WHO classification: Report of a developing country Pakistan.

Authors:  Sadia Sultan; Naseer Baloch; Zeeshan Ansar Ahmed; Syed Mohammed Irfan; Saira Parveen
Journal:  J Lab Physicians       Date:  2018 Jan-Mar
View more
  2 in total

1.  18F-FDG PET/CT-based radiomics nomogram could predict bone marrow involvement in pediatric neuroblastoma.

Authors:  Lijuan Feng; Xu Yang; Xia Lu; Ying Kan; Chao Wang; Dehui Sun; Hui Zhang; Wei Wang; Jigang Yang
Journal:  Insights Imaging       Date:  2022-09-04

2.  Comparison of FDG PET/CT and Bone Marrow Biopsy Results in Patients with Diffuse Large B Cell Lymphoma with Subgroup Analysis of PET Radiomics.

Authors:  Eun Ji Han; Joo Hyun O; Hyukjin Yoon; Seunggyun Ha; Ie Ryung Yoo; Jae Won Min; Joon-Il Choi; Byung-Ock Choi; Gyeongsin Park; Han Hee Lee; Young-Woo Jeon; Gi-June Min; Seok-Goo Cho
Journal:  Diagnostics (Basel)       Date:  2022-01-17
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.